Aktiespot

Premier Biomedical, Inc. (Premier Biomedical Inc) Aktie

BIEI

Geschlossen
$0.0011-0.0001 (-8.33%)
Chart wird geladen...

Premier Biomedical Inc

Eröffnung0.0011
Hoch0.0012
Tief0.0010
Volumen2.56M
P/EN/A
Marktkapitalisierung1.54M
52-Wochen-Hoch0.0020
52-Wochen-Tief0.0003
Durchschn. Volumen24.35M
DividendeN/A
Beta0.74
EPS-0.0100

Über Premier Biomedical, Inc. (Premier Biomedical Inc) Aktie

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.

Unternehmensinformationen

Börse: OTC Markets OTCID (OID)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Special og generisk
Adresse:
PO Box 25
16133 Jackson Center, United States
Telefon: + 724 633 7033

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: